ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 105 filers reported holding ALBIREO PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $11,097,275 | +13.7% | 513,525 | +1.9% | 0.64% | +12.4% |
| Q3 2022 | $9,760,000 | +5.5% | 504,138 | +8.2% | 0.57% | +26.6% |
| Q2 2022 | $9,251,000 | -34.7% | 465,804 | -1.9% | 0.45% | -20.9% |
| Q1 2022 | $14,169,000 | +32.8% | 474,991 | +3.7% | 0.56% | +49.1% |
| Q4 2021 | $10,667,000 | -32.7% | 458,011 | -9.8% | 0.38% | -35.2% |
| Q3 2021 | $15,840,000 | -11.8% | 507,681 | -0.5% | 0.58% | -8.5% |
| Q2 2021 | $17,958,000 | -11.1% | 510,467 | -10.9% | 0.64% | -2.9% |
| Q1 2021 | $20,195,000 | +109.2% | 572,899 | +122.6% | 0.66% | +93.5% |
| Q4 2020 | $9,654,000 | +231.2% | 257,372 | +194.6% | 0.34% | +190.6% |
| Q3 2020 | $2,915,000 | – | 87,358 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 480,000 | $14,318,000 | 9.25% |
| Decheng Capital Management III (Cayman), LLC | 518,342 | $15,462,000 | 4.74% |
| TANG CAPITAL MANAGEMENT LLC | 467,702 | $13,952,000 | 2.79% |
| Birchview Capital, LP | 113,000 | $3,371,000 | 2.43% |
| Privium Fund Management B.V. | 351,805 | $10,494,000 | 2.32% |
| Sio Capital Management, LLC | 144,546 | $4,312,000 | 1.43% |
| Perceptive Advisors | 2,360,139 | $70,403,000 | 1.41% |
| Chicago Capital, LLC | 1,011,744 | $30,180,000 | 1.30% |
| Endurant Capital Management LP | 120,834 | $3,604,000 | 0.95% |
| Nicholas Investment Partners, LP | 439,235 | $13,102,000 | 0.93% |